•  
  •  
  •  
  •  

2025-12-23 12:18:59

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  Bahrain

Stock Report

  • Wardwizard Foods and Beverages Ltd expands International Footprint with New Exports to Bahrain and Germany
  • KMEW's Fleet Expansion: River Pearl 18 Empowered for Sand Mining Contracts in Bahrain
  • Venus Remedies successfully obtains 3 new Marketing Authorizations for Enoxaparin from Bahrain
  • KMEW Emerges as First Indian Company with Bahrain's Marine Sand Extraction Certificate
  • Bhageria Industries Ltd receives its 1st International Solar EPC Project in Bahrain
  • Knowledge Marine & Engineering Works Ltd wins order worth Rs. 41.51 crores
  • Knowledge Marine's Milestone in Bahrain's Sand Market
  • Mukta A2 Multiplex WLL to manage EPIX Cinemas 10 screens multiplex at Bahrain
  • IndiGo announces Bahrain as its 25th International destination, launches flight connections in Mumbai
  • Roto Pumps Ltd receives export order from Bahrain

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024